Search results for: interstitial lung disease

Omeract How to Get into the “Act”

Peter Brooks, MD, Maarten Boers, MD,PhD, MSc, Lee S. Simon, MD, Vibeke Strand, MD,and Peter Tugwell, MD | April 1, 2010

Meet this international organization that focuses on rheumatology outcome measures

Progress Continues in Systemic Sclerosis

Daniel E. Furst, MD, Maureen D.Mayes, MD, MPH, Dinesh Khanna, MD,James R. Seibold, MD, Rajeev Saggar,MD, and Keith M. Sullivan, MD | March 1, 2010

Advances in genetics and potential therapies shed new light on the disease

The Heart-SCC Puzzle

Olga Kaloudi, MD, and Marco Matucci Cerinic, MD, PhD | May 1, 2009

Identifying and treating cardiac involvement in systemic sclerosis can be a challenge

Know Your Labs

Peter H. Schur, MD | February 1, 2009

A review of state-of-the-art testing for SLE and connective tissue disease.

Study Groups: Where Information and Networking Mix

From the College | September 1, 2008

ACR study groups provide an excellent forum for networking at the ACR/ARHP Annual Scientific Meeting and are among the most highly sought-after sessions each year. Although study groups are not eligible for CME credits, they provide an opportunity for the exchange of new ideas and in-depth presentations of information. These groups give attendees the opportunity to discuss cases and share experiences with colleagues who share a common interest in one disease, a group of related disorders, or a specialized field of study.

Myositis Mysteries

Kathleen M. Coyle, MD, Paul H. Plotz, MD, and Mark F. Gourley, MD | January 1, 2008

Why isn’t my myositis patient getting better?

Clinical Cutting Edge

Jane Jerrard | July 1, 2007

Updates on Sjogren’s syndrome, myositis, and vasculitis

Reading Rhuem

Robyn T. Domsic, MD; Gail C. Davis, RN, EdD; Mary Corr,MD | February 1, 2007

Handpicked Reviews of Contemporary Literature

Labored Breathing

Staff | January 1, 2007

Strategies to diagnose and manage dyspnea in the scleroderma patient

Trimethoprim Sulfamethoxazole Prophylaxis & Infections in Patients with GPA

Arthritis & Rheumatology | December 1, 2023

SAN DIEGO—In their study, Effect of Trimethoprim Sulfamethoxazole Prophylaxis on Infections During Treatment of Granulomatosis with Polyangiitis with Rituximab: A Population-Based Study, Mendel et al. assessed the relationship between trimethoprim sulfamethoxazole (TMP-SMX) and infection in patients undergoing treatment for granulomatosis with polyangiitis (GPA). Background/Purpose Infections during treatment of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV)…